[Selection of the peptides specifically binding to hepatoma by using phage display in vivo]

Bing Du1, Jing Yu, Zhong-liang Zhou

  • 1School of Life Science, East China Normal University, Shanghai 200062, China.

Abstract

Insights

Researchers successfully identified specific binding peptides for hepatoma cells using in vivo phage display. This method screens a peptide library to find molecules that target cancer tissues effectively.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Oncology

Context:

  • Hepatocellular carcinoma (HCC) is a major global health concern.
  • Targeted therapies require specific molecular binders for effective treatment.
  • Phage display technology offers a powerful tool for identifying such binders.

Purpose:

  • To screen for peptides that specifically bind to hepatoma cells and tissues.
  • To identify novel peptide motifs with potential diagnostic or therapeutic applications in HCC.

Summary:

  • The study employed an in vivo phage display approach using a twelve-peptide library injected into nude mice bearing BEL-7402 human hepatoma cells.
  • Following three rounds of screening, phage clones homing to tumor tissues were isolated, sequenced, and analyzed for target motifs.
  • Immunohistochemistry, titering, and cell ELISA were used for appraisal of phage-peptide binding specificity and distribution.

Impact:

  • Successfully identified specific phage-peptides that bind to hepatoma cells and tissues.
  • Demonstrates the efficacy of in vivo phage display for discovering targeted cancer binders.
  • Provides a foundation for developing targeted diagnostic agents or therapeutics for hepatoma.

Related Concept Videos